1. Soler EP, Ruiz VC. Epidemiology and risk factors of cerebral ischemia and ischemic heart diseases: similarities and differences. Curr Cardiol Rev 2010;6(3):138-49. [
DOI:10.2174/157340310791658785] [
PMID] [
]
2. Mosarrezaii Aghdam A, Khadem Vatan K, Kameli A. Investigating the distribution of risk factors for ischemic stroke and its relationship with involvement site and duration of hospitalization in Imam Khomeini Hospital in Urmia. A cross sectional descriptive study. Stud Med Sci 2019;30(4):329-34. [
URL]
3. Bousser MG, Kittner SJ. Oral contraceptives and stroke. Cephalalgia 2000;20(3):183-9. [
DOI:10.1046/j.1468-2982.2000.00040.x] [
PMID]
4. Gulløv AL, Koefoed BG, Petersen P. Bleeding During Warfarin and Aspirin Therapy in Patients with Atrial Fibrillation: The AFASAK 2 Study. Arch Intern Med 1999;159(12):1322-28. [
DOI:10.1001/archinte.159.12.1322] [
PMID]
5. Sarikaya H, Ferro J, Arnold M. Stroke prevention--medical and lifestyle measures. Eur Neurol 2015;73(3-4):150-7. [
DOI:10.1159/000367652] [
PMID]
6. Zhao W, Xiao ZJ, Zhao SP. The Benefits and Risks of Statin Therapy in Ischemic Stroke: A Review of the Literature. Neurol India 2019;67(4):983-92. [
DOI:10.4103/0028-3886.266274] [
PMID]
7. Zhao M, Li XW, Chen Z, Hao F, Tao SX, Yu HY et al. Neuro-Protective Role of Metformin in Patients with Acute Stroke and Type 2 Diabetes Mellitus via AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Pathway and Oxidative Stress. Med Sci Monit 2019;25:2186-94. [
DOI:10.12659/MSM.911250] [
PMID] [
]
8. Putaala J. Ischemic Stroke in Young Adults. Continuum (Minneap Minn) 2020;26(2):386-414. [
DOI:10.1212/CON.0000000000000833] [
PMID]
9. 9 Keener A, Sanossian N. Niacin for stroke prevention: evidence and rationale. CNS Neurosci Ther 2008;14(4):287-94. [
DOI:10.1111/j.1755-5949.2008.00055.x] [
PMID] [
]
10. Fauci A, Braumwald E, Kasper D, Hauser S, Longo D, Jameson J et al. Harrison 's principles of internal medicine. 17th Edition. McGraw-Hill 2008. [
URL]
11. Shirani M, Asgari K, Najafi M. An Investigation of Efficacy of Electromyography Biofeedback on Motor paralysis of the lower extremities in Patients with Ischemic and Hemorrhagic Strokes. Stud Med Sci 2018;28(11):698-707. [
URL]
12. Azarpazhooh MR, Etemadi MM, Donnan GA, Mokhber N, Majdi MR, Ghayour-Mobarhan M et al. Excessive incidence of stroke in Iran: evidence from the Mashhad Stroke Incidence Study (MSIS), a population-based study of stroke in the Middle East. Stroke 2010;41(1):e3-e10. [
DOI:10.1161/STROKEAHA.109.559708] [
PMID]
13. Tyagi SS. To Study the Medicine Use Evaluation in Stroke Patients in Hospital. J Med Sci Clin Res 2019;7(8):579-87. [
DOI:10.18535/jmscr/v7i8.98]
14. Wang W, Jiang B, Sun H, Ru X, Sun D, Wang L et al. NESS-China Investigators. Prevalence, Incidence, and Mortality of Stroke in China: Results from a Nationwide Population-Based Survey of 480 687 Adults. Circulation 2017;135(8):759-71. [
DOI:10.1161/CIRCULATIONAHA.116.025250] [
PMID]
15. Smajlović D. Strokes in young adults: epidemiology and prevention. Vasc Health Risk Manag 2015;11:157-64. [
DOI:10.2147/VHRM.S53203] [
PMID] [
]
16. Ahmadi Ahangar A, Sanaat A, Saghebi R. Investigating risk factors in stroke patients (Babol,1379-81). J. Babol Univ. Med. Sci 2005;7(3):55-60. (Persian) [
URL]
17. Jiang M, Ma C, Li H, Shen H, Li X, Sun Q et al. Sex Dimorphisms in Ischemic Stroke: From Experimental Studies to Clinic. Front Neurol 2020;11:504. [
DOI:10.3389/fneur.2020.00504] [
PMID] [
]
18. Kuriakose D, Xiao Z. Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives. Int J Mol Sci 2020;21(20):7609. [
DOI:10.3390/ijms21207609] [
PMID] [
]
19. Luitse MJ, Biessels GJ, Rutten GE, Kappelle LJ. Diabetes, hyperglycaemia, and acute ischaemic stroke. Lancet Neurol 2012;11(3):261-71. [
DOI:10.1016/S1474-4422(12)70005-4] [
PMID]
20. Chen R, Ovbiagele B, Feng W. Diabetes and Stroke: Epidemiology, Pathophysiology, Pharmaceuticals and Outcomes. Am J Med Sci 2016;351(4):380-6. [
DOI:10.1016/j.amjms.2016.01.011] [
PMID] [
]
21. Lau LH, Lew J, Borschmann K, Thijs V, Ekinci EI. Prevalence of diabetes and its effects on stroke outcomes: A meta-analysis and literature review. J Diabetes Investig 2019;10(3):780-792. [
DOI:10.1111/jdi.12932] [
PMID] [
]
22. El-Hajj M, Ajrouche R, Zein S, Rachidi S, Awada S, Al-Hajje A. Evaluation of risk factors and drug adherence in the occurrence of stroke in patients with atrial fibrillation. Pharm Pract (Granada) 2020;18(2):1860. [
DOI:10.18549/PharmPract.2020.2.1860] [
PMID] [
]
23. MacClellan LR, Giles W, Cole J, Wozniak M, Stern B, Mitchell BD et al. Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women study. Stroke 2007;38(9):2438-45. [
DOI:10.1161/STROKEAHA.107.488395] [
PMID]
24. Fijnheer R, van de Ven PJ, Erkelens DW. Psychiatrische medicatie als risicofactor voor fatale hittecollaps [Psychiatric drugs as risk factor in fatal heat stroke]. Ned Tijdschr Geneeskd 1995;139(27):1391-3. [
PMID]
25. Castilla-Guerra L, Fernandez-Moreno MDC, Leon-Jimenez D, Carmona-Nimo E. Antidiabetic drugs and stroke risk. Current evidence. Eur J Intern Med 2018;48:1-5. [
DOI:10.1016/j.ejim.2017.09.019] [
PMID]
26. Goyagi T, Nishikawa T, Tobe Y. Neuroprotective effects and suppression of ischemia-induced glutamate elevation by β1-adrenoreceptor antagonists administered before transient focal ischemia in rats. J Neurosurg Anesthesiol 2011;23(2):131-7. [
DOI:10.1097/ANA.0b013e31820369c1] [
PMID]
27. Sadrhaghighi G, Abbaszadeh S, Babataheri Sh, Garjani A, Soraya H. Effects of pre-treatment with metoprolol and diltiazem on cerebral ischemia/reperfusion-induced injuries. Braz J Pharm Sci 2022;58:e21086. [
DOI:10.1590/s2175-97902022e21086]
28. Zhu J, Chen N, Zhou M, Guo J, Zhu C, Zhou J et al. Calcium channel blockers versus other classes of drugs for hypertension. Cochrane Database Syst Rev 2022;1(1):CD003654. [
DOI:10.1002/14651858.CD003654.pub6] [
PMID] [
]
29. Regenhardt RW, Bennion DM, Sumners C. Cerebroprotective action of angiotensin peptides in stroke. Clin Sci (Lond) 2014;126(3):195-205. [
DOI:10.1042/CS20130324] [
PMID] [
]
30. Collins R, Armitage J, Parish S, Sleight P, Peto R; Heart Protection Study Collaborative Group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004;363(9411):757-67. [
DOI:10.1016/S0140-6736(04)15690-0] [
PMID]
31. Zhao W, Xiao ZJ, Zhao SP. The Benefits and Risks of Statin Therapy in Ischemic Stroke: A Review of the Literature. Neurol India 2019;67(4):983-92. [
DOI:10.4103/0028-3886.266274] [
PMID]
32. Christophe B, Karatela M, Sanchez J, Pucci J, Connolly ES. Statin Therapy in Ischemic Stroke Models: A Meta-Analysis. Transl Stroke Res 2020;11(4):590-600. [
DOI:10.1007/s12975-019-00750-7] [
PMID]
33. Karimipour M, Shojaei Zarghani S, Mohajer Milani M, Soraya H. Pre-Treatment with Metformin in Comparison with Post-Treatment Reduces Cerebral Ischemia Reperfusion Induced Injuries in Rats. Bull Emerg Trauma 2018;6(2):115-21. [
DOI:10.29252/beat-060205] [
PMID] [
]
34. Jia J, Cheng J, Ni J, Zhen X. Neuropharmacological Actions of Metformin in Stroke. Curr Neuropharmacol 2015;13(3):389-94. [
DOI:10.2174/1570159X13666150205143555] [
PMID] [
]
35. Ghazizadeh S, Tartibian B, Ghaderi Pakdel F. Preventive effect of 8 weeks moderate training on susceptible colon cancer factor (Insulin Growth Factor I and Insulin Growth Factor Binding Protein 3 in rats). Stud Med Sci 2018;28(12):759-69. [
URL]